Patients and physicians need better tools to make biologically-informed decisions about clinical trials.
Unlike traditional diagnostics vendors, we try to report everything we measure back to the patient and their care team.
We helped a recent patient find two new therapeutic options.
When it comes to identifying plausible therapeutic targets for our patients, refinement is as important as discovery.
We're bringing maximalist diagnostics to more patients.
.png)
.png)
